Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP)
Laura Francisco, Marta Cruz-Cañete, Carlos Pérez, José Antonio Couceiro, Enrique Otheo, Cristian Launes, Carlos Rodrigo, Ana Belén Jiménez, Marta Llorente, Abián Montesdeoca, José Rumbao, Cristina Calvo, Susana Frago, Alfredo Tagarro
10.1016/j.anpede.2023.09.006